Dr. Wang is Co-Leader of the Tumor Microenvironment Program at USC Norris Comprehensive Cancer Center and Director of Cancer Immunotherapy Program at CHLA/KECK School of Medicine. His research interests include cancer antigen discovery, cancer immunology and immunotherapy, innate immune signaling and regulation, and epigenetic regulation of stem cells and cancer. Wang is the Principal Investigator and Co-leader of multiple NIH-funded grants (R01, U54) and a Department of Defense (DoD) Grant on development of NY-ESO-1-specific TCR-engineered T cell immunotherapy for triple negative breast cancer.